ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MAGNETISMM-3 STUDY
M MohtyaM TomassonbB ArnulfcN BahlisdM PrinceeR NiesvizkyfP Rodrgue-OterogJ Martine-LopezhG KoehneiY JethavajA GabayankD StevenslA NookamN RajenS IidaoE LeippU ConteqA CzibereqA ViqueirarV BlunksA Lesokhint
a Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
b Holden Comprehensive Cancer Center, University of Iowa, Iowa City, United States
c Hôpital Saint-Louis, Paris, France
d Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
e Epworth Healthcare, Melbourne, Australia
f Weill Cornell Medical College – New York Presbyterian Hospital, New York, United States
g Clinica Universidad de Navarra, Madrid, Spain
h Hospital Universitario 12 DE OCTUBRE, Madrid, Spain
i Miami Cancer Institute, Miami, United States
j Indiana Blood & Marrow Transplant, Indianapolis, United States
k Beverly Hills Cancer Center, Beverly Hills, United States
l Norton Cancer Center, Louisville, United States
m Winship Cancer Institute, Atlanta, United States
n Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, United States
o Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
p Pfizer Inc, Cambridge, United States
q Pfizer Inc, New York, United States
r Pfizer SLU, Madrid, Spain
s Pfizer, São Paulo, Brazil
t Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, United States
Ver másRead
1229
Timeswas read the article
402
Total PDF
827
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 9 | 16 | 0 | 16 |
| 2025 8 | 79 | 20 | 99 |
| 2025 7 | 66 | 21 | 87 |
| 2025 6 | 51 | 22 | 73 |
| 2025 5 | 56 | 10 | 66 |
| 2025 4 | 37 | 15 | 52 |
| 2025 3 | 57 | 14 | 71 |
| 2025 2 | 52 | 20 | 72 |
| 2025 1 | 37 | 28 | 65 |
| 2024 12 | 28 | 16 | 44 |
| 2024 11 | 33 | 13 | 46 |
| 2024 10 | 30 | 18 | 48 |
| 2024 9 | 46 | 18 | 64 |
| 2024 8 | 39 | 20 | 59 |
| 2024 7 | 39 | 18 | 57 |
| 2024 6 | 37 | 21 | 58 |
| 2024 5 | 35 | 27 | 62 |
| 2024 4 | 42 | 16 | 58 |
| 2024 3 | 15 | 9 | 24 |
| 2024 2 | 10 | 13 | 23 |
| 2024 1 | 5 | 9 | 14 |
| 2023 12 | 6 | 17 | 23 |
| 2023 11 | 10 | 24 | 34 |
| 2023 10 | 1 | 13 | 14 |
Show all
